| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-06 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |